Word

LTS

Status

Registered

Status Code

700

Status Date

Tuesday, August 25, 2020

Serial Number

88308560

Registration Number

6133117

Registration Date

Tuesday, August 25, 2020

Mark Type

3000

Filing Date

Wednesday, February 20, 2019

Published for Opposition

Tuesday, June 9, 2020

Trademark Owner History

LTS Lohmann Therapie-Systeme AG - Original Registrant

Classifications

1 Unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; adhesives used in industry

5 Pharmaceutical and veterinary preparations, namely, injectable pharmaceutical and veterinary preparations for the prevention and treatment of disease, namely, infectious diseases, viral diseases, neurological diseases, central nervous system diseases, brain diseases, oral and dental diseases, inflammatory diseases, immune system diseases, dermatological diseases, sexually transmitted diseases, musculoskeletal diseases, psychiatric diseases, diseases of the spinal cord and motor disorders, cardiovascular diseases, diseases of the respiratory system, diseases treated by oncologists, gastroenterologists, opthalmologists, otologists, audolaryngologists, gynecologists, gerontologists, proctologists, and urologists by intracutaneous, intradermal, subcutaneous, intramuscular, intravenous and intra-articular injection, the aforesaid injection preparations being for needle-free injection and for injection by means of needle and cannula systems; injectable pharmaceutical and veterinary preparation therapeutic or prophylactic ingredients or diagnostic preparations, namely, pharmaceutical and therapeutic preparations for use with pets, laboratory animals, wild animals, zoo animals and livestock for the treatment and prevention of disease, namely, infectious diseases, viral diseases, neurological diseases, central nervous system diseases, brain diseases, oral and dental diseases, inflammatory diseases, immune system diseases, dermatological diseases, sexually transmitted diseases, musculoskeletal diseases, psychiatric diseases, diseases of the spinal cord and motor disorders, cardiovascular diseases, diseases of the respiratory system, diseases treated by oncologists, gastroenterologists, opthalmologists, otologists, audolaryngologists, gynecologists, gerontologists, proctologists, and urologists; pharmaceutical preparations for use in the gastrointestinal tract, subcutaneous use and for oral use for the treatment and prevention of disease, namely, infectious diseases, viral diseases, neurological diseases, central nervous system diseases, brain diseases, oral and dental diseases, inflammatory diseases, immune system diseases, dermatological diseases, sexually transmitted diseases, musculoskeletal diseases, psychiatric diseases, diseases of the spinal cord and motor disorders, cardiovascular diseases, diseases of the respiratory system, diseases treated by oncologists, gastroenterologists, opthalmologists, otologists, audolaryngologists, gynecologists, gerontologists, proctologists, and urologists; medicines for administration in the form of plasters and wafers containing active ingredients, namely, medicines for the treatment of gastrointestinal diseases; medical plasters containing active ingredients for transdermal administration of active ingredients; medical plasters containing active ingredients for topical processing of active ingredients and for manufacturing active ingredient-free laminates; sanitary preparations for medical purposes; food for babies; dietary supplements for humans and animals; medical and surgical plasters in the nature of materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides

10 Surgical, medical and veterinary apparatus and instruments, namely, instruments and apparatus for injecting substances, in particular, infusion and injection device for administering drugs, needle-free, via needles, by cannulae, and through an injection systems comprised primarily of a needle-free injection device; dropper bottle for administering medication, sold empty; medicine delivery devices and instruments, namely, microneedles and microneedle assemblies and structures for use in dermal, transdermal, mucosal and transmucosal administration of pharmaceuticals and biotechnological molecules; medicine delivery devices and instruments, namely, microneedles and microneedle assemblies for use in dermal, transdermal, mucosal and transmucosal sampling of bodily fluids; medical devices and instruments for administering pharmaceuticals and biotechnological molecules using needle-like microstructures; plaster needles for medical purposes for use on the skin; injection device for pharmaceuticals, namely, medical injection device for administering drugs and parts for the aforesaid goods, in particular, microneedles and microneedle assemblies for use in administering pharmaceuticals and biotechnological molecules, excluding dental apparatus and instruments; artificial limbs and eyes, excluding dental implants and prosthesis; suture materials; all of the aforesaid goods excluding dental products

42 Scientific and technological services and research and design relating thereto, namely, chemical analysis and industrial research services in the field of chemical analysis; industrial analysis, namely, chemical analysis and industrial research services in the field of chemical analysis; design and development of computer hardware and software

44 Medical services; veterinary services; hygienic and beauty care for human beings and animals; agriculture, horticulture and forestry services, namely, horticulture services

The colors dark green, medium green, light green and red are claimed as a feature of the mark.
The mark consists of the letters "LTS" in red, upper case, block letters to the left of which is a design consisting of an arrangement of three L-shaped forms in dark, medium and light green.
LOHMANN THERAPIE SYSTEME

Trademark Events

Aug 25, 2020

Registered-Principal Register

Jun 9, 2020

Official Gazette Publication Confirmation E-Mailed

Jun 9, 2020

Published For Opposition

May 20, 2020

Notification Of Notice Of Publication E-Mailed

May 4, 2020

Assigned To Lie

Apr 27, 2020

Approved For Pub - Principal Register

Apr 27, 2020

Examiner's Amendment Entered

Apr 27, 2020

Notification Of Examiners Amendment E-Mailed

Apr 27, 2020

Examiners Amendment E-Mailed

Apr 27, 2020

Examiners Amendment -Written

Apr 21, 2020

Teas/Email Correspondence Entered

Apr 21, 2020

Correspondence Received In Law Office

Apr 21, 2020

Teas Response To Office Action Received

Nov 7, 2019

Notification Of Non-Final Action E-Mailed

Nov 7, 2019

Non-Final Action E-Mailed

Nov 7, 2019

Non-Final Action Written

Oct 30, 2019

Teas/Email Correspondence Entered

Oct 30, 2019

Correspondence Received In Law Office

Oct 30, 2019

Teas Response To Office Action Received

May 3, 2019

Notification Of Non-Final Action E-Mailed

May 3, 2019

Non-Final Action E-Mailed

May 3, 2019

Non-Final Action Written

May 1, 2019

Assigned To Examiner

Mar 21, 2019

Notice Of Design Search Code E-Mailed

Mar 12, 2019

New Application Office Supplied Data Entered In Tram

Feb 23, 2019

New Application Entered In Tram